Psychedelic Spotlight
2023-09-05

Preparing Healthcare Providers for the Psychedelic Therapy Shift

Currently, MDMA-assisted therapy for PTSD and psilocybin for depression disorders await approval from the FDA. Meanwhile, practitioners are creating spaces to give their patients this revolutionary experience. 

Related News